Nulife Ltd

Oncolytics Biotech Inc., based in Calgary, Alberta, is committed to enhancing the lives of cancer patients through innovative therapies. Their lead product, pelareorep, is a unique immunotherapy designed to activate the immune system against various cancer types by selectively targeting cancer cells and bolstering immune response. The company focuses on developing pelareorep for use alongside standard cancer treatments, aiming to improve outcomes for patients with conditions such as pancreatic and breast cancers. Oncolytics collaborates with key opinion leaders and regulatory bodies to optimize the development of this promising treatment, supported by encouraging data from various clinical trials. Generated from the website

McKesson Canada is a diversified healthcare leader committed to advancing health outcomes for all by providing comprehensive solutions that enhance patient access to life-changing therapies. With a significant role in the distribution of medications across the country, the company leverages clinical expertise and innovative technology to improve the cost and quality of healthcare. Specializing in pharmaceutical distribution, patient care services, and retail pharmacy solutions, McKesson Canada plays a vital part in the healthcare landscape. The organization is dedicated to supporting chronic conditions and rare diseases while ensuring equitable access to essential treatments through advanced healthcare solutions. Generated from the website